Martin Tammemagi
Martin Tammemagi
Professor of Epidemiology, Brock University
Verified email at
TitleCited byYear
The national lung screening trial: overview and study design
National Lung Screening Trial Research Team
Radiology 258 (1), 243-253, 2011
Probability of cancer in pulmonary nodules detected on first screening CT
A McWilliams, MC Tammemagi, JR Mayo, H Roberts, G Liu, K Soghrati, ...
New England Journal of Medicine 369 (10), 910-919, 2013
Overdiagnosis in low-dose computed tomography screening for lung cancer
EF Patz, P Pinsky, C Gatsonis, JRD Sicks, BS Kramer, MC Tammemägi, ...
JAMA internal medicine 174 (2), 269-274, 2014
Selection criteria for lung-cancer screening
MC Tammemägi, HA Katki, WG Hocking, TR Church, N Caporaso, ...
New England Journal of Medicine 368 (8), 728-736, 2013
Targeting of low-dose CT screening according to the risk of lung-cancer death
SA Kovalchik, M Tammemagi, CD Berg, NE Caporaso, TL Riley, M Korch, ...
New England Journal of Medicine 369 (3), 245-254, 2013
Comorbidity and survival disparities among black and white patients with breast cancer
CM Tammemagi, D Nerenz, C Neslund-Dudas, C Feldkamp, ...
Jama 294 (14), 1765-1772, 2005
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the US Preventive Services Task Force
HJ de Koning, R Meza, SK Plevritis, K Ten Haaf, VN Munshi, J Jeon, ...
Annals of internal medicine 160 (5), 311-320, 2014
Smoking and lung cancer survival: the role of comorbidity and treatment
CM Tammemagi, C Neslund-Dudas, M Simoff, P Kvale
Chest 125 (1), 27-37, 2004
Impact of comorbidity on lung cancer survival
CM Tammemagi, C Neslund‐Dudas, M Simoff, P Kvale
International journal of cancer 103 (6), 792-802, 2003
Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation
CM Tammemagi, PF Pinsky, NE Caporaso, PA Kvale, WG Hocking, ...
Journal of the national cancer institute 103 (13), 1058-1068, 2011
Evaluation of the lung cancer risks at which to screen ever-and never-smokers: screening rules applied to the PLCO and NLST cohorts
MC Tammemägi, TR Church, WG Hocking, GA Silvestri, PA Kvale, ...
PLoS medicine 11 (12), e1001764, 2014
Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate
GY Jin, D Lynch, A Chawla, K Garg, MC Tammemagi, H Sahin, S Misumi, ...
Radiology 268 (2), 563-571, 2013
Impact of lung cancer screening results on smoking cessation
MC Tammemägi, CD Berg, TL Riley, CR Cunningham, KL Taylor
JNCI: Journal of the National Cancer Institute 106 (6), 2014
Long-term prognostic role of functional limitations among women with breast cancer
D Braithwaite, WA Satariano, B Sternfeld, RA Hiatt, PA Ganz, ...
Journal of the National Cancer Institute 102 (19), 1468-1477, 2010
In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival
CM Tammemagi, C Neslund-Dudas, M Simoff, P Kvale
Journal of clinical epidemiology 57 (6), 597-609, 2004
Meta-analyses of p53 tumor suppressor gene alterations and clinicopathological features in resected lung cancers
MC Tammemagi, JR McLaughlin, SB Bull
Cancer Epidemiology and Prevention Biomarkers 8 (7), 625-634, 1999
Hypertension is an independent predictor of survival disparity between African‐American and white breast cancer patients
D Braithwaite, CM Tammemagi, DH Moore, EM Ozanne, RA Hiatt, ...
International Journal of Cancer 124 (5), 1213-1219, 2009
Identification of 14-3-3𝛉 as an Antigen that Induces a Humoral Response in Lung Cancer
SR Pereira-Faca, R Kuick, E Puravs, Q Zhang, AL Krasnoselsky, ...
Cancer Research 67 (24), 12000-12006, 2007
Soluble mesothelin-related peptide and osteopontin as markers of response in malignant mesothelioma
P Wheatley-Price, B Yang, D Patsios, D Patel, C Ma, W Xu, N Leighl, ...
Journal of clinical oncology 28 (20), 3316-3322, 2010
p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival.
AG Casson, M Tammemagi, S Eskandarian, M Redston, J McLaughlin, ...
Molecular Pathology 51 (2), 71, 1998
The system can't perform the operation now. Try again later.
Articles 1–20